A First in Human Study to Assess the Safety,Tolerability and Pharmacokinetics of ONO-2808 in Healthy Participants
Status:
Recruiting
Trial end date:
2021-08-29
Target enrollment:
Participant gender:
Summary
This is a first in human study to determine the safety, tolerability and pharmacokinetics of
ONO-2808 in healthy adult participants. The study will be conducted in 4 parts: Part A, a
single-ascending dose part with an assessment of the potential food effects in non-Japanese
adult participants; Part B, a single-dose part to assess the effect of age in non-Japanese
elderly participants; Part C, a multiple-ascending dose part with ONO-2808 administered to
non-Japanese adult participants; and Part D, a single and multiple doses part to assess the
ethnicity difference between Japanese and non-Japanese healthy participants.